CFO of Agile Therapeutics Inc (30-Year Financial, Insider Trades) Dennis Reilly (insider trades) bought 75,000 shares of AGRX on 03/04/2020 at an average price of $2.33 a share. The total cost of this purchase was $174,750.
Agile Therapeutics Inc is a women's health specialty pharmaceutical company. The Company is engaged in the development and commercialization of transdermal patch technology for use in contraception products. Agile Therapeutics Inc has a market cap of $201.980 million; its shares were traded at around $2.32 . Agile Therapeutics Inc had annual average EBITDA growth of 26.00% over the past five years. GuruFocus has detected 1 severe warning sign with Agile Therapeutics Inc. .
CEO Recent Trades:
- CEO Alfred Altomari bought 10,000 shares of AGRX stock on 02/27/2020 at the average price of $2.71. The price of the stock has decreased by 14.39% since.
CFO Recent Trades:
- CFO Dennis Reilly bought 75,000 shares of AGRX stock on 03/04/2020 at the average price of $2.33. The price of the stock has decreased by 0.43% since.
Directors and Officers Recent Trades:
- 10% Owner Life Sciences Maste Perceptive bought 3,000,000 shares of AGRX stock on 02/25/2020 at the average price of $3. The price of the stock has decreased by 22.67% since.
For the complete insider trading history of AGRX, click here
.
